INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 155,008 Value ($000) $620 Avg Close — Range —
Q1 2025
Shares 233,561 Value ($000) $213 Avg Close — Range —
Q4 2024
Shares 252,722 Value ($000) $700 Avg Close — Range —
Q3 2024
Shares 447,317 Value ($000) $2,339 Avg Close — Range —
Q2 2024
Shares 361,868 Value ($000) $1,614 Avg Close — Range —
Q1 2024
Shares 409,923 Value ($000) $3,140 Avg Close — Range —
Q4 2023
Shares 363,372 Value ($000) $1,548 Avg Close — Range —
Q3 2023
Shares 53,888 Value ($000) $226 Avg Close — Range —
Q2 2023
Shares 34,389 Value ($000) $192 Avg Close — Range —
Q4 2022
Shares 11,924 Value ($000) $13 Avg Close — Range —
Q2 2022
Shares 12,505 Value ($000) $0 Avg Close — Range —
Q1 2022
Shares 13,255 Value ($000) $54 Avg Close — Range —
Q4 2021
Shares 13,239 Value ($000) $90 Avg Close — Range —
Q3 2021
Shares 16,565 Value ($000) $192 Avg Close — Range —
Q2 2021
Shares 19,310 Value ($000) $329 Avg Close — Range —
Q1 2021
Shares 23,790 Value ($000) $471 Avg Close — Range —
Q4 2020
Shares 20,839 Value ($000) $430 Avg Close — Range —
Q3 2020
Shares 13,680 Value ($000) $360 Avg Close — Range —